Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Herbal DispatchLUFFF -7.79% Equity-to-Asset is 0.29 as of Mar. 2026, which is 59% below its 10-year median of 0.70. The stock has 3 warning signs investors should review. Among 1,006 Drug Manufacturers companies, Herbal Dispatch ranks worse than 83.9% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Herbal Dispatch's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $1.65 Mil. Herbal Dispatch's Total Assets for the quarter that ended in Mar. 2026 was $5.75 Mil.
Therefore, Herbal Dispatch's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.29.
The historical rank and industry rank for Herbal Dispatch's Equity-to-Asset or its related term are showing as below:
LUFFF'
s Equity-to-Asset Range Over the Past 10 Years
Min: -1.29 Med: 0.7 Max: 0.98
Current: 0.29
During the past 13 years, the highest Equity to Asset Ratio of Herbal Dispatch was 0.98. The lowest was -1.29. And the median was 0.70.
LUFFF's Equity-to-Asset is ranked worse than 83.9% of 1006
companies
in the Drug Manufacturers industry
Industry Median: 0.61
vs LUFFF: 0.29
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Herbal Dispatch Equity-to-Asset Related Terms
Herbal Dispatch Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Herbal Dispatch's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Herbal Dispatch's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Herbal Dispatch Equity-to-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Herbal Dispatch's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Herbal Dispatch's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Herbal Dispatch's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Herbal Dispatch (LUFFF) has a Equity-to-Asset of 0.29 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Herbal Dispatch and its competitors. This is 59% below median its historical median of 0.70. According to the industry distribution chart, Herbal Dispatch ranks #844 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 83.9%.
Is Herbal Dispatch's Equity-to-Asset too high?
Herbal Dispatch's current Equity-to-Asset of 0.29 is 59% below median its 10-year median of 0.70. The Drug Manufacturers industry median Equity-to-Asset is 0.61. Herbal Dispatch's value of 0.29 is 52.5% below this industry median. Based on the distribution chart, Herbal Dispatch ranks #844 out of 1006 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Herbal Dispatch's Equity-to-Asset compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Herbal Dispatch ranks #844 out of 1006 companies for Equity-to-Asset. This places Herbal Dispatch in the lower half of its industry. The industry median Equity-to-Asset is 0.61. Herbal Dispatch's value of 0.29 is 52.5% below this benchmark. While the company's 10-year median is 0.70 vs. the industry median of 0.61, Herbal Dispatch has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.61, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Herbal Dispatch's current Equity-to-Asset of 0.29 is 52.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Herbal Dispatch and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Herbal Dispatch's current Equity-to-Asset is 0.29, which is 59% below median its own 10-year median of 0.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Herbal Dispatch stock overvalued right now?
Based on GuruFocus' analysis, Herbal Dispatch (LUFFF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.06, compared to a current price of $0.03 — trading 55.6% below its estimated fair value. The current Equity-to-Asset is 0.29, which is 59% below median its 10-year median of 0.70 and 52.5% below the Drug Manufacturers industry median of 0.61. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Herbal Dispatch (LUFFF), the current Equity-to-Asset is 0.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Herbal Dispatch Inc owns and operates cannabis e-commerce platforms in both Canada and the United States and is dedicated to providing top-quality cannabis to informed consumers at affordable pricing. The company's flagship cannabis marketplace, Herbal Dispatch, is a trusted source for exclusive access to small-batch craft cannabis flowers and a wide array of other product formats. It generates revenue in one reportable segment: cannabis and cannabis-related products. Geographically, the company generates the majority of its revenue from Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LUFFF has been successfully added to your 
